Related Experiment Video
Updated: Jun 26, 2026
Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices
Published on: June 13, 2025
OK-432 sclerotherapy in head and neck lymphangiomas: long-term follow-up result
Jae Chul Yoo1, Youngjin Ahn, Yune Syung Lim
1Department of Otorhinolaryngology, Seoul National University College of Medicine, Seoul, Korea.
Introduction:
Nonsurgical treatments, such as sclerotherapy have been attempted for head and neck lymphagiomas. Of the available sclerosing agents, picibanil has shown satisfactory short-term treatment results in many studies, but no study has presented long-term treatment results. Accordingly, in the present study, the authors retrospectively reviewed the long-term treatment results of picibanil sclerotherapy.
Materials And Methods:
Fifty-five lymphangioma patients who underwent picibanil sclerotherapy were enrolled. Data about initial and long-term response, recurrence, and excision rate were collected.
Results:
Initial response rates were 83.5 percent and long-term response rates were 76.3 percent.
Conclusion:
Initial and the long-term response rate were equally good for lymphangioma.
